Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 03 03 2024
accepted: 05 09 2024
medline: 16 9 2024
pubmed: 16 9 2024
entrez: 15 9 2024
Statut: epublish

Résumé

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that is globally increasing in prevalence. The rise of ASD can be partially attributed to diagnostic expansion and advocacy efforts; however, the interplay between genetic predisposition and modern environmental exposures is likely driving a true increase in incidence. A range of evidence indicates that prenatal exposures are critical. Infection during pregnancy, gestational diabetes, and maternal obesity are established risk factors for ASD. Emerging areas of research include the effects of maternal use of selective serotonin reuptake inhibitors, antibiotics, and exposure to toxicants during pregnancy on brain development and subsequent ASD. The underlying pathways of these risk factors remain uncertain, with varying levels of evidence implicating immune dysregulation, mitochondrial dysfunction, oxidative stress, gut microbiome alterations, and hormonal disruptions. This narrative review assesses the evidence of contributing prenatal environmental factors for ASD and associated mechanisms as potential targets for novel prevention strategies.

Identifiants

pubmed: 39278907
doi: 10.1186/s12916-024-03617-3
pii: 10.1186/s12916-024-03617-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

393

Informations de copyright

© 2024. The Author(s).

Références

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. 2013.
doi: 10.1176/appi.books.9780890425596
Hyman SL, Levy SE, Myers SM, Kuo DZ, Apkon S, Davidson LF, et al. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1):e20193447.
pubmed: 31843864 doi: 10.1542/peds.2019-3447
Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022;15(5):778–90.
pubmed: 35238171 pmcid: 9310578 doi: 10.1002/aur.2696
Ratto AB, Kenworthy L, Yerys BE, Bascom J, Wieckowski AT, White SW, et al. What about the girls? Sex-based differences in autistic traits and adaptive skills. J Autism Dev Disord. 2018;48(5):1698–711.
pubmed: 29204929 pmcid: 5925757 doi: 10.1007/s10803-017-3413-9
Hansen SN, Schendel DE, Parner ET. Explaining the Increase in the prevalence of autism spectrum disorders. JAMA Pediatr. 2015;169(1):56.
pubmed: 25365033 doi: 10.1001/jamapediatrics.2014.1893
Frye RE, Cakir J, Rose S, Palmer RF, Austin C, Curtin P. Physiological mediators of prenatal environmental influences in autism spectrum disorder. BioEssays. 2021;43(9):2000307.
doi: 10.1002/bies.202000307
Tong L, Kalish BT. The impact of maternal obesity on childhood neurodevelopment. J Perinatol. 2021;41(5):928–39.
pubmed: 33249428 doi: 10.1038/s41372-020-00871-0
Tioleco N, Silberman AE, Stratigos K, Banerjee-Basu S, Spann MN, Whitaker AH, et al. Prenatal maternal infection and risk for autism in offspring: a meta-analysis. Autism Res. 2021;14(6):1296–316.
pubmed: 33720503 doi: 10.1002/aur.2499
Rowland J, Wilson CA. The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis. Sci Rep. 2021;11(1):5136.
pubmed: 33664319 pmcid: 7933135 doi: 10.1038/s41598-021-84573-3
Ponsonby A-L, Symeonides C, Saffery R, Mueller JF, O’Hely M, Sly PD, et al. Prenatal phthalate exposure, oxidative stress-related genetic vulnerability and early life neurodevelopment: a birth cohort study. Neurotoxicology. 2020;80:20–8.
pubmed: 32479765 doi: 10.1016/j.neuro.2020.05.006
Hagberg KW, Robijn AL, Jick SS. Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol. 2018;10:1599–612.
pubmed: 30464639 pmcid: 6219268 doi: 10.2147/CLEP.S180618
Hamad AF, Alessi-Severini S, Mahmud SM, Brownell M, Kuo IF. Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study. PLoS One. 2019;14(8):e0221921.
pubmed: 31465485 pmcid: 6715235 doi: 10.1371/journal.pone.0221921
Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–92.
pubmed: 23226953 pmcid: 3513682 doi: 10.31887/DCNS.2012.14.3/pchaste
Qiu S, Qiu Y, Li Y, Cong X. Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses. Transl Psychiatry. 2022;12(1):249.
pubmed: 35705542 pmcid: 9200752 doi: 10.1038/s41398-022-02009-6
Careaga M, Murai T, Bauman MD. Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry. 2017;81(5):391–401.
pubmed: 28137374 doi: 10.1016/j.biopsych.2016.10.020
Frye RE, Cakir J, Rose S, Palmer RF, Austin C, Curtin P, et al. Mitochondria may mediate prenatal environmental influences in autism spectrum disorder. J Pers Med. 2021;11(3):218.
pubmed: 33803789 pmcid: 8003154 doi: 10.3390/jpm11030218
Mandic-Maravic V, Mitkovic-Voncina M, Pljesa-Ercegovac M, Savic-Radojevic A, Djordjevic M, Pekmezovic T, et al. Autism spectrum disorders and perinatal complications—Is oxidative stress the connection? Front Psychiatry. 2019;10:675.
pubmed: 31681027 pmcid: 6798050 doi: 10.3389/fpsyt.2019.00675
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–63.
pubmed: 24315484 pmcid: 3897394 doi: 10.1016/j.cell.2013.11.024
Worsham W, Dalton S, Bilder DA. The prenatal hormone milieu in autism spectrum disorder. Front Psychiatry. 2021;12:655438.
pubmed: 34276434 pmcid: 8280339 doi: 10.3389/fpsyt.2021.655438
Ornoy A, Weinstein-Fudim L, Ergaz Z. Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol. 2015;56:155–69.
pubmed: 26021712 doi: 10.1016/j.reprotox.2015.05.007
Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, et al. Gene× Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psych. 2014;5:53.
Schaaf CP, Betancur C, Yuen RKC, Parr JR, Skuse DH, Gallagher L, et al. A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat Rev Genet. 2020;21(6):367–76.
pubmed: 32317787 pmcid: 10357004 doi: 10.1038/s41576-020-0231-2
Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163(10):907.
pubmed: 19805709 doi: 10.1001/archpediatrics.2009.98
Hansen SN, Schendel DE, Francis RW, Windham GC, Bresnahan M, Levine SZ, et al. Recurrence risk of autism in siblings and cousins: a multinational, population-based study. J Am Acad Child Adolesc Psychiatry. 2019;58(9):866–75.
pubmed: 30851399 pmcid: 6708733 doi: 10.1016/j.jaac.2018.11.017
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25(1):63–77.
pubmed: 7792363 doi: 10.1017/S0033291700028099
Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445–9.
pubmed: 17363630 pmcid: 2993504 doi: 10.1126/science.1138659
Quesnel-Vallières M, Weatheritt RJ, Cordes SP, Blencowe BJ. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet. 2019;20(1):51–63.
pubmed: 30390048 doi: 10.1038/s41576-018-0066-2
Goin-Kochel RP, Abbacchi A, Constantino JN, Autism Genetic Resource Exchange C. Lack of evidence for increased genetic loading for autism among families of affected females. Autism. 2007;11(3):279–86.
pubmed: 17478580 doi: 10.1177/1362361307076857
Szatmari P, Liu XQ, Goldberg J, Zwaigenbaum L, Paterson AD, Woodbury-Smith M, et al. Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet. 2012;159(1):5–12.
doi: 10.1002/ajmg.b.31238
Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol. 2011;9(6):e1001081.
pubmed: 21695109 pmcid: 3114757 doi: 10.1371/journal.pbio.1001081
Napolitano A, Schiavi S, La Rosa P, Rossi-Espagnet MC, Petrillo S, Bottino F, et al. Sex differences in autism spectrum disorder: diagnostic, neurobiological, and behavioral features. Front Psychiatry. 2022;13:889636.
pubmed: 35633791 pmcid: 9136002 doi: 10.3389/fpsyt.2022.889636
Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020;11(1):69.
pubmed: 32912338 pmcid: 7488083 doi: 10.1186/s13229-020-00370-1
Harris JC. The origin and natural history of autism spectrum disorders. Nat Neurosci. 2016;19(11):1390–1.
pubmed: 27786188 doi: 10.1038/nn.4427
Chess S. Autism in children with congenital rubella. J Autism Child Schizophr. 1971;1(1):33–47.
pubmed: 5172438 doi: 10.1007/BF01537741
Hutton J. Does rubella cause autism: a 2015 reappraisal? Front Hum Neurosci. 2016;10:25.
pubmed: 26869906 pmcid: 4734211 doi: 10.3389/fnhum.2016.00025
Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 2003;33(4):455–9.
pubmed: 12959425 doi: 10.1023/A:1025023131029
Jiang H-Y, Xu L-L, Shao L, Xia R-M, Yu Z-H, Ling Z-X, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun. 2016;58:165–72.
pubmed: 27287966 doi: 10.1016/j.bbi.2016.06.005
Yin H, Wang Z, Liu J, Li Y, Liu L, Huang P, et al. Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders. Life Sci. 2023;324:121734.
pubmed: 37105442 doi: 10.1016/j.lfs.2023.121734
Atladóttir HÓ, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40(12):1423–30.
pubmed: 20414802 doi: 10.1007/s10803-010-1006-y
Atladottir HO, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics. 2012;130(6):e1447–54.
pubmed: 23147969 doi: 10.1542/peds.2012-1107
Zerbo O, Iosif A-M, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I. Is Maternal Influenza or fever during pregnancy associated with autism or developmental delays? results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study. J Autism Dev Disord. 2013;43(1):25–33.
pubmed: 22562209 pmcid: 3484245 doi: 10.1007/s10803-012-1540-x
Nudel R, Thompson WK, Børglum AD, Hougaard DM, Mortensen PB, Werge T, et al. Maternal pregnancy-related infections and autism spectrum disorder—the genetic perspective. Transl Psychiatry. 2022;12(1):334.
pubmed: 35974006 pmcid: 9381559 doi: 10.1038/s41398-022-02068-9
Girchenko P, Lahti-Pulkkinen M, Heinonen K, Reynolds RM, Laivuori H, Lipsanen J, et al. Persistently high levels of maternal antenatal inflammation are associated with and mediate the effect of prenatal environmental adversities on neurodevelopmental delay in the offspring. Biol Psychiat. 2020;87(10):898–907.
pubmed: 31987493 doi: 10.1016/j.biopsych.2019.12.004
Patel S, Dale RC, Rose D, Heath B, Nordahl CW, Rogers S, et al. Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity. Transl Psychiatry. 2020;10(1):286.
pubmed: 32796821 pmcid: 7429839 doi: 10.1038/s41398-020-00976-2
Rudolph MD, Graham AM, Feczko E, Miranda-Dominguez O, Rasmussen JM, Nardos R, et al. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat Neurosci. 2018;21(5):765–72.
pubmed: 29632361 pmcid: 5920734 doi: 10.1038/s41593-018-0128-y
Tartaglione AM, Villani A, Ajmone-Cat MA, Minghetti L, Ricceri L, Pazienza V, et al. Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes. Transl Psychiatry. 2022;12(1):384.
pubmed: 36104346 pmcid: 9474453 doi: 10.1038/s41398-022-02149-9
Bokobza C, Van Steenwinckel J, Mani S, Mezger V, Fleiss B, Gressens P. Neuroinflammation in preterm babies and autism spectrum disorders. Pediatr Res. 2019;85(2):155–65.
pubmed: 30446768 doi: 10.1038/s41390-018-0208-4
Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007;27(40):10695–702.
pubmed: 17913903 pmcid: 2387067 doi: 10.1523/JNEUROSCI.2178-07.2007
Wu W-L, Hsiao EY, Yan Z, Mazmanian SK, Patterson PH. The placental interleukin-6 signaling controls fetal brain development and behavior. Brain Behav Immun. 2017;62:11–23.
pubmed: 27838335 doi: 10.1016/j.bbi.2016.11.007
Lim AI, McFadden T, Link VM, Han S-J, Karlsson R-M, Stacy A, et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. 2021;373(6558):eabf3002.
pubmed: 34446580 doi: 10.1126/science.abf3002
Koga K, Mor G. Toll-like receptors at the maternal–fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol. 2010;63(6):587–600.
pubmed: 20367625 pmcid: 3025804 doi: 10.1111/j.1600-0897.2010.00848.x
Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV, et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933–9.
pubmed: 26822608 pmcid: 4782964 doi: 10.1126/science.aad0314
Yasumatsu K, Nagao JI, Arita-Morioka KI, Narita Y, Tasaki S, Toyoda K, et al. Bacterial-induced maternal interleukin-17A pathway promotes autistic-like behaviors in mouse offspring. Exp Anim. 2020;69(2):250–60.
pubmed: 32009087 pmcid: 7220715 doi: 10.1538/expanim.19-0156
Hsiao EY, Patterson PH. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun. 2011;25(4):604–15.
pubmed: 21195166 doi: 10.1016/j.bbi.2010.12.017
Dahlgren J, Samuelsson A-M, Jansson T, Holmäng A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res. 2006;60(2):147–51.
pubmed: 16864694 doi: 10.1203/01.pdr.0000230026.74139.18
Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation. 2011;8(1):52.
pubmed: 21595886 pmcid: 3114764 doi: 10.1186/1742-2094-8-52
Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. Science. 2016;353(6301):772–7.
pubmed: 27540164 pmcid: 5650490 doi: 10.1126/science.aag3194
Meyer U. Neurodevelopmental resilience and susceptibility to maternal immune activation. Trends Neurosci. 2019;42(11):793–806.
pubmed: 31493924 doi: 10.1016/j.tins.2019.08.001
Gyllenhammer LE, Rasmussen JM, Bertele N, Halbing A, Entringer S, Wadhwa PD, et al. Maternal inflammation during pregnancy and offspring brain development: the role of mitochondria. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(5):498–509.
pubmed: 34800727
Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457-70.e13.
pubmed: 27667687 pmcid: 5863951 doi: 10.1016/j.cell.2016.08.064
Nair S, Sobotka KS, Joshi P, Gressens P, Fleiss B, Thornton C, et al. Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia. 2019;67(6):1047–61.
pubmed: 30637805 doi: 10.1002/glia.23587
M Wilkins H, H Swerdlow R. Relationships between mitochondria and neuroinflammation: implications for Alzheimer’s disease. Curr Top Med Chem. 2016;16(8):849–57.
doi: 10.2174/1568026615666150827095102
Swanepoel T, Möller M, Harvey BH. N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges. Psychopharmacology. 2018;235(1):351–68.
pubmed: 29116368 doi: 10.1007/s00213-017-4776-5
Anitha A, Nakamura K, Thanseem I, Matsuzaki H, Miyachi T, Tsujii M, et al. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2013;23(3):294–302.
pubmed: 23088660 doi: 10.1111/bpa.12002
Kato Y, Yokokura M, Iwabuchi T, Murayama C, Harada T, Goto T, et al. Lower availability of mitochondrial complex I in anterior cingulate cortex in autism: a positron emission tomography study. Am J Psychiatry. 2023;180(4):277–84.
pubmed: 36069020 doi: 10.1176/appi.ajp.22010014
Liong S, Miles MA, Mohsenipour M, Liong F, Hill-Yardin EL, Selemidis S. Influenza A virus infection during pregnancy causes immunological changes in gut-associated lymphoid tissues of offspring mice. Am J Physiol Gastrointest Liver Physiol. 2023;325(3):G230–8.
pubmed: 37431584 pmcid: 10435073 doi: 10.1152/ajpgi.00062.2023
Liong S, Oseghale O, To EE, Brassington K, Erlich JR, Luong R, et al. Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice. Proc Natl Acad Sci. 2020;117(40):24964–73.
pubmed: 32958663 pmcid: 7547222 doi: 10.1073/pnas.2006905117
Li N, Yang J, Zhang J, Liang C, Wang Y, Chen B, et al. Correlation of gut microbiome between ASD children and mothers and potential biomarkers for risk assessment. Genomics Proteomics Bioinformatics. 2019;17(1):26–38.
pubmed: 31026579 pmcid: 6520911 doi: 10.1016/j.gpb.2019.01.002
Han VX, Patel S, Jones HF, Nielsen TC, Mohammad SS, Hofer MJ, et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl Psychiatry. 2021;11(1):71.
pubmed: 33479207 pmcid: 7820474 doi: 10.1038/s41398-021-01198-w
Bordeleau M, Lacabanne C, de Fernández Cossío L, Vernoux N, Savage JC, González-Ibáñez F, et al. Microglial and peripheral immune priming is partially sexually dimorphic in adolescent mouse offspring exposed to maternal high-fat diet. J Neuroinflamm. 2020;17:1–28.
doi: 10.1186/s12974-020-01914-1
Xavier S, Soch A, Younesi S, Malik S, Spencer SJ, Sominsky L. Maternal diet before and during pregnancy modulates microglial activation and neurogenesis in the postpartum rat brain. Brain Behav Immun. 2021;98:185–97.
pubmed: 34418500 doi: 10.1016/j.bbi.2021.08.223
Bilbo SD, Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J. 2010;24(6):2104–15.
pubmed: 20124437 doi: 10.1096/fj.09-144014
Piazza FV, Segabinazi E, De Meireles ALF, Mega F, Spindler CDF, Augustin OA, et al. Severe uncontrolled maternal hyperglycemia induces microsomia and neurodevelopment delay accompanied by apoptosis, cellular survival, and neuroinflammatory deregulation in rat offspring hippocampus. Cell Mol Neurobiol. 2019;39(3):401–14.
pubmed: 30739252 doi: 10.1007/s10571-019-00658-8
Muller CL, Anacker AMJ, Veenstra-Vanderweele J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience. 2016;321:24–41.
pubmed: 26577932 doi: 10.1016/j.neuroscience.2015.11.010
Kim S, Kim H, Yim YS, Ha S, Atarashi K, Tan TG, et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017;549(7673):528–32.
pubmed: 28902840 pmcid: 5870873 doi: 10.1038/nature23910
Bolton JL, Marinero S, Hassanzadeh T, Natesan D, Le D, Belliveau C, et al. Gestational exposure to air pollution alters cortical volume, microglial morphology, and microglia-neuron interactions in a sex-specific manner. Front Synaptic Neurosci. 2017;9:10.
pubmed: 28620294 pmcid: 5449437 doi: 10.3389/fnsyn.2017.00010
Xiao L, Feng J, Zhang W, Pan J, Wang M, Zhang C, et al. Autism-like behavior of murine offspring induced by prenatal exposure to progestin is associated with gastrointestinal dysfunction due to claudin-1 suppression. Febs j. 2023;290(13):3369–82.
pubmed: 36855792 doi: 10.1111/febs.16761
de Oliveira MR. Fluoxetine and the mitochondria: a review of the toxicological aspects. Toxicol Lett. 2016;258:185–91.
pubmed: 27392437 doi: 10.1016/j.toxlet.2016.07.001
Emmerzaal TL, Nijkamp G, Veldic M, Rahman S, Andreazza AC, Morava E, et al. Effect of neuropsychiatric medications on mitochondrial function: for better or for worse. Neurosci Biobehav Rev. 2021;127:555–71.
pubmed: 34000348 doi: 10.1016/j.neubiorev.2021.05.001
Houttu N, Mokkala K, Laitinen K. Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles. Clin Nutr. 2018;37(6 Pt A):1955–66.
pubmed: 29338886 doi: 10.1016/j.clnu.2017.12.013
Kuang Y-S, Lu J-H, Li S-H, Li J-H, Yuan M-Y, He J-R, et al. Connections between the human gut microbiome and gestational diabetes mellitus. GigaScience. 2017;6(8):1–12.
pubmed: 29046044 pmcid: 5647792 doi: 10.1093/gigascience/gix058
Pronovost GN, Yu KB, Elena J, Telang SS, Chen AS, Vuong HE, et al. The maternal microbiome promotes placental development in mice. Sci Adv. 2023;9(40):eadk1887.
pubmed: 37801498 pmcid: 10558122 doi: 10.1126/sciadv.adk1887
Kratsman N, Getselter D, Elliott E. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. Neuropharmacology. 2016;102:136–45.
pubmed: 26577018 doi: 10.1016/j.neuropharm.2015.11.003
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80.
pubmed: 22863002 pmcid: 3505857 doi: 10.1016/j.cell.2012.07.008
Nuriel-Ohayon M, Neuman H, Koren O. Microbial changes during pregnancy, birth, and infancy. Front Microbiol. 2016;7:1031.
pubmed: 27471494 pmcid: 4943946 doi: 10.3389/fmicb.2016.01031
Reigstad CS, Salmonson CE, Rainey JF III, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2015;29(4):1395.
pubmed: 25550456 doi: 10.1096/fj.14-259598
Rodnyy AY, Kondaurova EM, Tsybko AS, Popova NK, Kudlay DA, Naumenko VS. The brain serotonin system in autism. Rev Neurosci. 2023;35(1):1–20. https://doi.org/10.1515/revneuro-2023-0055 .
Chen CM, Chou HC, Yang YCSH. Maternal antibiotic treatment disrupts the intestinal microbiota and intestinal development in neonatal mice. Front Microbiol. 2021;12:684233.
pubmed: 34177871 pmcid: 8220820 doi: 10.3389/fmicb.2021.684233
Agrawal R, Agrawal A, Jacson MJ. Maternal obesity and autism spectrum disorders in offspring. Indian J Child Health. 2022;9(10):178–82.
doi: 10.32677/ijch.v9i10.3690
Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519–25.
pubmed: 14990416 doi: 10.1097/01.AOG.0000113621.53602.7a
Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM, Sjödin A, et al. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4-and 5-year-old children: the HOME study. Environ Health Perspect. 2014;122(5):513–20.
pubmed: 24622245 pmcid: 4014765 doi: 10.1289/ehp.1307261
Symeonides C, Vacy K, Thomson S, Tanner S, Chua HK, Dixit S, et al. Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotype. Nat Commun. 2024;15(1):6367.
pubmed: 39112449 pmcid: 11306638 doi: 10.1038/s41467-024-48897-8
Bhat RS, Alonazi M, Al-Daihan S, El-Ansary A. Prenatal SSRI exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain. Metabolites. 2023;13(2):310.
pubmed: 36837929 pmcid: 9963091 doi: 10.3390/metabo13020310
Thomson S, Drummond K, O’Hely M, Symeonides C, Chandran C, Mansell T, et al. Increased maternal non-oxidative energy metabolism mediates association between prenatal di-(2-ethylhexyl) phthalate (DEHP) exposure and offspring autism spectrum disorder symptoms in early life: A birth cohort study. Environ Int. 2023;171:107678.
pubmed: 36516674 doi: 10.1016/j.envint.2022.107678
Tanner S, Thomson S, Drummond K, O’Hely M, Symeonides C, Mansell T, et al. A pathway-based genetic score for oxidative stress: an indicator of host vulnerability to phthalate-associated adverse neurodevelopment. Antioxidants. 2022;11(4):659.
pubmed: 35453345 pmcid: 9030597 doi: 10.3390/antiox11040659
Xu G, Jing J, Bowers K, Liu B, Bao W. Maternal diabetes and the risk of autism spectrum disorders in the offspring: a systematic review and meta-analysis. J Autism Dev Disord. 2014;44(4):766–75.
pubmed: 24057131 pmcid: 4181720 doi: 10.1007/s10803-013-1928-2
Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425–34.
pubmed: 25871668 doi: 10.1001/jama.2015.2707
Kong L, Chen X, Gissler M, Lavebratt C. Relationship of prenatal maternal obesity and diabetes to offspring neurodevelopmental and psychiatric disorders: a narrative review. Int J Obes. 2020;44(10):1981–2000.
doi: 10.1038/s41366-020-0609-4
Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.
pubmed: 35613728 pmcid: 9131781 doi: 10.1136/bmj-2021-067946
Khambule L, George JA. The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. In: Guest, P. (eds) reviews on biomarker studies of metabolic and metabolism-related disorders. Advances in experimental medicine and biology, vol 1134. Cham: Springer; 2019. https://doi.org/10.1007/978-3-030-12668-1_12 .
Sotgiu S, Manca S, Gagliano A, Minutolo A, Melis MC, Pisuttu G, et al. Immune regulation of neurodevelopment at the mother–foetus interface: the case of autism. Clin Transl Immunol. 2020;9(11):e1211.
doi: 10.1002/cti2.1211
Berenbaum SA, Beltz AM. How early hormones shape gender development. Curr Opin Behav Sci. 2016;7:53–60.
pubmed: 26688827 pmcid: 4681519 doi: 10.1016/j.cobeha.2015.11.011
McCarthy MM. Multifaceted origins of sex differences in the brain. Philos Trans R Soc B Biol Sci. 2016;371(1688):20150106.
doi: 10.1098/rstb.2015.0106
Behura SK, Kelleher AM, Spencer TE. Evidence for functional interactions between the placenta and brain in pregnant mice. FASEB J. 2019;33(3):4261.
pubmed: 30521381 doi: 10.1096/fj.201802037R
Bale TL. The placenta and neurodevelopment: sex differences in prenatal vulnerability. Dialogues Clin Neurosci. 2016;18(4):459–64.
pubmed: 28179817 pmcid: 5286731 doi: 10.31887/DCNS.2016.18.4/tbale
Aljumaiah MM, Alonazi MA, Al-Dbass AM, Almnaizel AT, Alahmed M, Soliman DA, et al. Association of maternal diabetes and autism spectrum disorders in offspring: a study in a rodent model of autism. J Mol Neurosci. 2022;72(2):349–58.
pubmed: 34562183 doi: 10.1007/s12031-021-01912-9
Harrington RA, Lee L-C, Crum RM, Zimmerman AW, Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014;133(5):e1241–8.
pubmed: 24733881 pmcid: 4006441 doi: 10.1542/peds.2013-3406
Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5(null):449–59.
pubmed: 24255601 pmcid: 3832387 doi: 10.2147/CLEP.S53009
Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry. 2016;55(5):359–66.
pubmed: 27126849 pmcid: 4851729 doi: 10.1016/j.jaac.2016.02.013
Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K. Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: a systematic review and meta-analysis. Reprod Toxicol. 2016;66:31–43.
pubmed: 27667009 doi: 10.1016/j.reprotox.2016.09.013
Mezzacappa A, Lasica P-A, Gianfagna F, Cazas O, Hardy P, Falissard B, et al. Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(6):555–63.
pubmed: 28418571 doi: 10.1001/jamapediatrics.2017.0124
Ornoy A. Valproic acid in pregnancy: How much are we endangering the embryo and fetus? Reprod Toxicol. 2009;28(1):1–10.
pubmed: 19490988 doi: 10.1016/j.reprotox.2009.02.014
Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140–56.
pubmed: 26043938 pmcid: 4737249 doi: 10.1002/bdrc.21096
Kobayashi T, Matsuyama T, Takeuchi M, Ito S. Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis. Reprod Toxicol. 2016;65:170–8.
pubmed: 27474253 doi: 10.1016/j.reprotox.2016.07.016
Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr. 2016;39(3):76.
pubmed: 27346915 pmcid: 4919171
Yin W, Pulakka A, Reichenberg A, Kolevzon A, Ludvigsson JF, Risnes K, et al. Association between parental psychiatric disorders and risk of offspring autism spectrum disorder: a Swedish and Finnish population-based cohort study. Lancet Regional Health Eur. 2024;40:100902.
doi: 10.1016/j.lanepe.2024.100902
Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):85–102.
pubmed: 12551730 doi: 10.1016/S0278-5846(02)00338-X
Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14.
pubmed: 23222853 pmcid: 3708472 doi: 10.1097/MED.0b013e32835bc703
Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, Mizukami H, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16(7):804–8.
pubmed: 20581837 pmcid: 2921604 doi: 10.1038/nm.2173
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, et al. A transient placental source of serotonin for the fetal forebrain. Nature. 2011;472(7343):347–50.
pubmed: 21512572 pmcid: 3084180 doi: 10.1038/nature09972
Sujan AC, Öberg AS, Quinn PD, D’Onofrio BM. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019;60(4):356–76.
pubmed: 30515808 doi: 10.1111/jcpp.13004
da LD Barros M, Manhaes-de-castro R, Alves DT, Quevedo OG, Toscano AE, Bonnin A, et al. Long term effects of neonatal exposure to fluoxetine on energy balance: a systematic review of experimental studies. Eur J Pharmacol. 2018;833:298–306.
doi: 10.1016/j.ejphar.2018.06.013
De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013;8(10):e76993.
pubmed: 24130822 pmcid: 3793965 doi: 10.1371/journal.pone.0076993
Lee E, Cho J, Kim KY. The association between autism spectrum disorder and pre- and postnatal antibiotic exposure in childhood—A systematic review with meta-analysis. Int J Environ Res Public Health. 2019;16(20):4042.
pubmed: 31652518 pmcid: 6843945 doi: 10.3390/ijerph16204042
Wimberley T, Agerbo E, Pedersen CB, Dalsgaard S, Horsdal HT, Mortensen PB, et al. Otitis media, antibiotics, and risk of autism spectrum disorder. Autism Res. 2018;11(10):1432–40.
pubmed: 30284386 doi: 10.1002/aur.2015
Holingue C, Brucato M, Ladd-Acosta C, Hong X, Volk H, Mueller NT, et al. Interaction between maternal immune activation and antibiotic use during pregnancy and child risk of autism spectrum disorder. Autism Res. 2020;13(12):2230–41.
pubmed: 33067915 pmcid: 7839062 doi: 10.1002/aur.2411
Moosa A, Shu H, Sarachana T, Hu VW. Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm Behav. 2018;101:13–21.
pubmed: 29042182 doi: 10.1016/j.yhbeh.2017.10.003
Haggerty DK, Strakovsky RS, Talge NM, Carignan CC, Glazier-Essalmi AN, Ingersoll BR, et al. Prenatal phthalate exposures and autism spectrum disorder symptoms in low-risk children. Neurotoxicol Teratol. 2021;83:106947.
pubmed: 33412243 pmcid: 7825926 doi: 10.1016/j.ntt.2021.106947
Oulhote Y, Lanphear B, Braun JM, Webster GM, Arbuckle TE, Etzel T, et al. Gestational exposures to phthalates and folic acid, and autistic traits in Canadian children. Environ Health Perspect. 2020;128(2):027004.
pubmed: 32073305 pmcid: 7064316 doi: 10.1289/EHP5621
Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect. 2011;119(6):873–7.
pubmed: 21156395 doi: 10.1289/ehp.1002835
Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry. 2014;4(2):e360.
pubmed: 24518398 pmcid: 3944636 doi: 10.1038/tp.2014.4
Dutheil F, Comptour A, Morlon R, Mermillod M, Pereira B, Baker JS, et al. Autism spectrum disorder and air pollution: a systematic review and meta-analysis. Environ Pollut. 2021;278:116856.
pubmed: 33714060 doi: 10.1016/j.envpol.2021.116856
Dou JF, Schmidt RJ, Volk HE, Nitta MM, Feinberg JI, Newschaffer CJ, Croen LA, Hertz-Picciotto I, Fallin MD, Bakulski KM. Exposure to heavy metals in utero and autism spectrum disorder at age 3: a meta-analysis of two longitudinal cohorts of siblings of children with autism. Environ Health. 2024;23(1):62. https://doi.org/10.1186/s12940-024-01101-2 .
Ding M, Shi S, Qie S, Li J, Xi X. Association between heavy metals exposure (cadmium, lead, arsenic, mercury) and child autistic disorder: a systematic review and meta-analysis. Front Pediatr. 2023;11:1169733.
pubmed: 37469682 pmcid: 10353844 doi: 10.3389/fped.2023.1169733
Lyall K, Croen LA, Sjödin A, Yoshida CK, Zerbo O, Kharrazi M, et al. Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder and intellectual disability. Environ Health Perspect. 2017;125(3):474–80.
pubmed: 27548254 doi: 10.1289/EHP277
Schmidt RJ, Kogan V, Shelton JF, Delwiche L, Hansen RL, Ozonoff S, et al. Combined prenatal pesticide exposure and folic acid intake in relation to autism spectrum disorder. Environ Health Perspect. 2017;125(9):097007.
pubmed: 28934093 pmcid: 5915192 doi: 10.1289/EHP604
von Ehrenstein OS, Ling C, Cui X, Cockburn M, Park AS, Yu F, et al. Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study. Bmj. 2019;364:l962.
doi: 10.1136/bmj.l962
Román P, Ruiz-González C, Rueda-Ruzafa L, Cardona D, Requena M, Alarcón R. Exposure to environmental pesticides and the risk of autism spectrum disorders: a population-based case-control study. Medicina. 2024;60(3):479.
pubmed: 38541205 pmcid: 10972278 doi: 10.3390/medicina60030479
Goodman CV, Green R, Dacosta A, Flora D, Lanphear B, Till C. Sex difference of pre- and post-natal exposure to six developmental neurotoxicants on intellectual abilities: a systematic review and meta-analysis of human studies. Environ Health. 2023;22(1):80.
pubmed: 37978510 pmcid: 10655280 doi: 10.1186/s12940-023-01029-z
Stamova B, Green PG, Tian Y, Hertz-Picciotto I, Pessah IN, Hansen R, et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res. 2011;19:31–48.
pubmed: 19937285 doi: 10.1007/s12640-009-9137-7
Ijomone OM, Olung NF, Akingbade GT, Okoh COA, Aschner M. Environmental influence on neurodevelopmental disorders: potential association of heavy metal exposure and autism. J Trace Elem Med Biol. 2020;62:126638.
pubmed: 32891009 pmcid: 7655547 doi: 10.1016/j.jtemb.2020.126638
Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR. A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit. 2011;17(12):CR677.
pubmed: 22129897 pmcid: 3628138 doi: 10.12659/MSM.882125
Sandin S, Schendel D, Magnusson P, Hultman C, Surén P, Susser E, et al. Autism risk associated with parental age and with increasing difference in age between the parents. Mol Psychiatry. 2016;21(5):693–700.
pubmed: 26055426 doi: 10.1038/mp.2015.70
Lugo Marín J, Alviani Rodríguez-Franco M, Mahtani Chugani V, MagánMaganto M, DíezVilloria E, Canal BR. Prevalence of schizophrenia spectrum disorders in average-IQ adults with autism spectrum disorders: a meta-analysis. J Autism Dev Disord. 2018;48(1):239–50.
pubmed: 28980099 doi: 10.1007/s10803-017-3328-5
Mutluer T, Aslan Genç H, Özcan Morey A, YapiciEser H, Ertinmaz B, Can M, et al. Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: a meta-analysis. Front Psychiatry. 2022;13:856208.
pubmed: 35693977 pmcid: 9186340 doi: 10.3389/fpsyt.2022.856208
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24–32.
pubmed: 22296988 doi: 10.1093/ije/dyr236

Auteurs

Chloe Love (C)

Child Health Research Unit, Barwon Health, Geelong, Australia.
The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.

Luba Sominsky (L)

Child Health Research Unit, Barwon Health, Geelong, Australia.
The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.

Martin O'Hely (M)

The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.
Murdoch Children's Research Institute, Parkville, Australia.

Michael Berk (M)

The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.

Peter Vuillermin (P)

Child Health Research Unit, Barwon Health, Geelong, Australia.
The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia.
Murdoch Children's Research Institute, Parkville, Australia.

Samantha L Dawson (SL)

The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia. samantha.dawson@deakin.edu.au.
Murdoch Children's Research Institute, Parkville, Australia. samantha.dawson@deakin.edu.au.
Food and Mood Centre, Deakin University, Geelong, Australia. samantha.dawson@deakin.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH